Amy C Anderson

This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: University of Connecticut, Promiliad Biopharma Inc.. Active years: 2013-2020.

USPTO Granted Patents = 5

% Patents Active = 60.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 5(Granted Patents)

Location History:

Storrs, CT (US) (2013 - 2017)
(2020)

Company Filing History:

5 out of 780

University of Connecticut

patents

1 out of 1

Promiliad Biopharma Inc.

patent

where one patent can have more than one assignee

Years Active: 2013-2020

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10870625 - Zwitterionic propargyl-linked antifolates useful for treating bacterial infections (2020-12-22),

2. 9790158 - Substituted tropolone derivatives and methods of use (2017-10-17),

3. 9382213 - Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase (2016-07-05),

4. 8853228 - Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase (2014-10-07),

5. 8426432 - Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties (2013-04-23),

Title: Amy C Anderson: Innovator in Antifolate Compounds

Introduction

Amy C Anderson is a prominent inventor based in Storrs, Connecticut. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating bacterial infections. With a total of 5 patents to her name, Anderson's work has the potential to impact medical treatments significantly.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Zwitterionic propargyl-linked antifolates useful for treating bacterial infections." This patent discloses compounds that can inhibit dihydrofolate reductase (DHFR) and offers methods for treating various infections, including bacterial, fungal, and protozoal infections. Another notable patent involves "Substituted tropolone derivatives and methods of use," which focuses on compounds that serve as histone deacetylase (HDAC) inhibitors. These innovations highlight her commitment to advancing medical science.

Career Highlights

Amy C Anderson has worked with esteemed institutions, including the University of Connecticut and Promiliad Biopharma Inc. Her experience in these organizations has allowed her to collaborate with other experts in the field and contribute to significant advancements in pharmaceutical research.

Collaborations

Throughout her career, Anderson has collaborated with notable colleagues such as Dennis L Wright and Eric William Scocchera. These partnerships have fostered an environment of innovation and have led to the development of her impactful patents.

Conclusion

Amy C Anderson's contributions to the field of pharmaceuticals through her innovative patents demonstrate her dedication to improving medical treatments. Her work continues to inspire future advancements in the industry.